AML
News
Study quantifies 5-year survival rates for blood cancers
A new study shows that 5-year survival rates for US patients with hematologic malignancies have increased greatly since the 1950s, but there is...
From the Journals
Clonal hematopoiesis increases risk for therapy-related cancers
Small pre-leukemic clones left behind after treatment for non-myeloid malignancies appear to increase the risk for therapy-related myelodysplasia...
News
Bank could help docs identify optimal AML treatment, team says
Research published in Nature Genetics suggests a knowledge bank can reveal the optimal treatment for patients with acute myeloid leukemia (AML...
News
Predicting response to cytarabine in AML patients
New research suggests the protein SAMHD1 could be used to predict which patients with acute myeloid leukemia (AML) will respond to treatment...
News
Obesity-associated protein linked to AML
Preclinical research indicates that a protein associated with obesity is also involved in the development of acute myeloid leukemia (AML) and may...
News
Infection in AML patient prompts discovery
The quest to understand a prolonged infection in an infant with acute myeloid leukemia (AML) has led to the discovery of a mutation that allows...
News
Drugs may be effective against hematologic, other cancers
Image courtesy of PNAS A diabetes medication and an antihypertensive drug may prove effective in the treatment of hematologic malignancies and...
Conference Coverage
Combos prove no better than 7+3 for AML
SAN DIEGO—Neither a 2-drug combination nor a 3-drug combination is superior to 7+3 chemotherapy in younger patients with previously untreated...
News
FDA places AML trials on full, partial clinical hold
The US Food and Drug Administration (FDA) has placed holds on 3 early stage trials of vadastuximab talirine (SGN-CD33A) in acute myeloid leukemia...
Commentary
FOUND IN TRANSLATION Minimal nomenclature and maximum sensitivity complicate MRD measures
Real time quantitative polymerase chain reaction (RT-qPCR) and next generation sequencing (NGS) requires a leukemia-specific abnormality but has...
News
Intermittent fasting fights ALL, not AML, in mice
Photo by Steve Berger Intermittent fasting inhibits the development and progression of acute lymphoblastic leukemia (ALL), according to...